Corvus Pharmaceuticals, Inc.CRVSNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank91
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-0.53
↑ 58% vs avg
Percentile
P91
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
-1.25
Historical baseline
PeriodValueYoY Change
TTM-0.53+48.0%
2024-1.02-81.2%
2023-0.56+36.8%
2022-0.89+13.6%
2021-1.03-415.0%
2020-0.20+86.6%
2019-1.49+12.9%
2018-1.71+37.1%
2017-2.72-15.3%
2016-2.36-